Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MyStromalCell: Adipose-derived MSCs in Chronic Myocardial Ischemia
NCT01449032Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Apr 2010
- Primary completion
- Jan 2014
- Modality
- Gene Editing, Gene Silencing, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of vascular endothelial growth factor a165-stimulated adipose-derived mesenchymal stromal cells in chronic myocardial ischemia (CMI), sponsored by Rigshospitalet. Started Apr 2010; status: completed.
02
Drugs
vascular endothelial growth factor a165-stimulated adipose-derived mesenchymal stromal cells
03
Conditions
chronic myocardial ischemia (CMI)
Beyond the preview
Go deeper on NCT01449032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01449032.